ClearFlow | Improve Cardiac Surgery Outcomes

📍 Irvine, United States🗓 Founded 2007👥 22 employees💰 Last funded Jan 2012
ClearFlow helps cardiac surgery professionals improve outcomes and advance healing through sustainable medical technologies that protect a patient's quality of life. Chest tubes used in heart and lung surgery frequently become obstructed by blood clots. When these tubes fail, the fluid can be retained; complications could include postoperative atrial fibrillation (POAF), acute kidney injury, or stroke. Reinterventions can slow recovery and bring a significant increase in the cost of care. The PleuraFlow® Active Clearance Technology® (ACT) System prevents chest tube failure and enables caregivers to manage postoperative bleeding safely, reliably, and efficiently. Reach out to our sales team here on LinkedIn or visit our website.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2007
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in ClearFlow | Improve Cardiac Surgery Outcomes?
ClearFlow | Improve Cardiac Surgery Outcomes has 1 investors on record on gritt.io, 1 mid-stage.
When did ClearFlow | Improve Cardiac Surgery Outcomes last raise funding?
The most recent investment in ClearFlow | Improve Cardiac Surgery Outcomes recorded on gritt.io was in January 2012.
When was ClearFlow | Improve Cardiac Surgery Outcomes founded?
ClearFlow | Improve Cardiac Surgery Outcomes was founded in 2007.
What industry is ClearFlow | Improve Cardiac Surgery Outcomes in?
ClearFlow | Improve Cardiac Surgery Outcomes operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is ClearFlow | Improve Cardiac Surgery Outcomes based?
ClearFlow | Improve Cardiac Surgery Outcomes is headquartered in Irvine, United States.